Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5767 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-109 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
filingDate |
2015-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2017-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-WO2015141826-A1 |
titleOfInvention |
Antibody having inhibitory activity against hepatitis C virus |
abstract |
The present invention provides an anti-hepatitis C virus E2 protein antibody or antigen-binding antibody fragment having hepatitis C virus (HCV) infection inhibitory activity. The present invention also provides an anti-hepatitis C virus E2 protein antibody or antigen-binding antibody fragment which has a specific variable region, has an inhibitory activity against hepatitis C virus (HCV) infection, and exhibits the ability to suppress the appearance of escape mutants. To do. |
priorityDate |
2014-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |